Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | affects expression | ISO | Cdc37 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of CDC37 mRNA | CTD | PMID:22206623 | 14-Deoxy-11,12-didehydroandrographolide | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of CDC37 mRNA | CTD | PMID:22101062 | 17alpha-ethynylestradiol | affects expression | ISO | Cdc37 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of CDC37 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CDC37 mRNA | CTD | PMID:16174780 | 17alpha-ethynylestradiol | multiple interactions | ISO | Cdc37 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDC37 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | Cdc37 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of CDC37 mRNA | CTD | PMID:16174780 and PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of CDC37 protein] and Tetrachlorodibenzodioxin promotes the reaction [CDC37 protein binds to SRC protein] | CTD | PMID:17223712 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cdc37 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CDC37 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cdc37 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDC37 mRNA | CTD | PMID:16960034 and PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDC37 mRNA | CTD | PMID:16960034 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cdc37 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDC37 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects localization | ISO | CDC37 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the localization of CDC37 protein | CTD | PMID:17223712 | 2,4,6-tribromophenol | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 mRNA and [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 protein | CTD | PMID:16317707 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of CDC37 protein | CTD | PMID:31675489 | 4,4'-sulfonyldiphenol | affects expression | ISO | CDC37 (Homo sapiens) | 6480464 | bisphenol S affects the expression of CDC37 protein | CTD | PMID:31945527 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC37 mRNA | CTD | PMID:36041667 | acetylsalicylic acid | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Aspirin results in decreased expression of CDC37 mRNA | CTD | PMID:15928584 | aristolochic acid A | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of CDC37 mRNA and aristolochic acid I results in increased expression of CDC37 protein | CTD | PMID:33212167 | arsenous acid | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CDC37 mRNA | CTD | PMID:17530438 | benzene | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Benzene results in decreased expression of CDC37 mRNA | CTD | PMID:16188087 and PMID:20036648 | bexarotene | increases expression | EXP | | 6480464 | bexarotene results in increased expression of CDC37 mRNA | CTD | PMID:16648578 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CDC37 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC37 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | Cdc37 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CDC37 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CDC37 mRNA | CTD | PMID:33296240 | bisphenol A | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CDC37 mRNA and bisphenol A results in decreased expression of CDC37 protein | CTD | PMID:29275510 and PMID:31675489 | Bisphenol B | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of CDC37 protein | CTD | PMID:34186270 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC37 mRNA | CTD | PMID:36041667 | bortezomib | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Bortezomib results in increased expression of CDC37 mRNA | CTD | PMID:17895889 | cadmium atom | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC37 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC37 mRNA | CTD | PMID:35301059 | cannabidiol | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [Cannabidiol co-treated with moringin] results in increased expression of CDC37 mRNA | CTD | PMID:30096889 | carbon nanotube | decreases expression | ISO | Cdc37 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | carbon nanotube | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Nanotubes and Carbon results in increased expression of CDC37 mRNA | CTD | PMID:15585362 | cerium trichloride | increases expression | ISO | Cdc37 (Mus musculus) | 6480464 | cerous chloride results in increased expression of CDC37 mRNA | CTD | PMID:23573234 | chloropicrin | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of CDC37 mRNA | CTD | PMID:26352163 | cisplatin | increases expression | ISO | Cdc37 (Mus musculus) | 6480464 | Cisplatin results in increased expression of CDC37 mRNA | CTD | PMID:21151649 | clofibrate | decreases expression | ISO | Cdc37 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of CDC37 mRNA | CTD | PMID:17585979 | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDC37 mRNA | CTD | PMID:17602206 | cobalt dichloride | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of CDC37 mRNA | CTD | PMID:19376846 | copper atom | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of CDC37 mRNA and [Thiosemicarbazones binds to Copper] which results in increased expression of CDC37 protein | CTD | PMID:20931265 and PMID:30911355 | copper(0) | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of CDC37 mRNA and [Thiosemicarbazones binds to Copper] which results in increased expression of CDC37 protein | CTD | PMID:20931265 and PMID:30911355 | coumarin | increases phosphorylation | ISO | CDC37 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of CDC37 protein | CTD | PMID:35688186 | diarsenic trioxide | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CDC37 mRNA | CTD | PMID:17530438 | diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of CDC37 mRNA | CTD | PMID:22546817 | diazinon | increases methylation | ISO | CDC37 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of CDC37 gene | CTD | PMID:22964155 | dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of CDC37 mRNA | CTD | PMID:16122865 | disodium selenite | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of CDC37 mRNA | CTD | PMID:16705456 | doxorubicin | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of CDC37 mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CDC37 protein | CTD | PMID:23301498 | epoxiconazole | decreases expression | ISO | Cdc37 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CDC37 mRNA | CTD | PMID:35436446 | FR900359 | increases phosphorylation | ISO | CDC37 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of CDC37 protein | CTD | PMID:37730182 | geldanamycin | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | geldanamycin inhibits the reaction [HSP90AA1 protein binds to SRC protein binds to CDC37 protein] and geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of CDC37 protein] | CTD | PMID:17223712 | hydralazine | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CDC37 mRNA | CTD | PMID:17183730 | isoprenaline | multiple interactions | EXP | | 6480464 | [Isoproterenol co-treated with POSTN protein] results in decreased expression of CDC37 mRNA | CTD | PMID:30303030 | ivermectin | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CDC37 protein | CTD | PMID:32959892 | lead(0) | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Lead results in decreased expression of CDC37 mRNA | CTD | PMID:19921347 | Mesaconitine | decreases expression | EXP | | 6480464 | mesaconitine results in decreased expression of CDC37 protein | CTD | PMID:37182599 | methidathion | increases expression | ISO | Cdc37 (Mus musculus) | 6480464 | methidathion results in increased expression of CDC37 mRNA | CTD | PMID:34813904 | N-methyl-4-phenylpyridinium | increases expression | ISO | Cdc37 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CDC37 protein | CTD | PMID:26558463 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 mRNA more ... | CTD | PMID:16317707 and PMID:17602206 | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of CDC37 mRNA | CTD | PMID:22546817 | niclosamide | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | CDC37 protein binds to and results in increased susceptibility to Niclosamide analog | CTD | PMID:28284560 | nitroglycerin | increases expression | EXP | | 6480464 | Nitroglycerin results in increased expression of CDC37 mRNA | CTD | PMID:12102619 | oxaliplatin | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | oxaliplatin results in increased expression of CDC37 mRNA | CTD | PMID:17762391 | palbociclib | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | palbociclib inhibits the reaction [CDC37 protein binds to CDK4 protein] and palbociclib inhibits the reaction [CDC37 protein binds to CDK6 protein] | CTD | PMID:29091774 | paracetamol | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CDC37 mRNA | CTD | PMID:22230336 | platycodin D | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | platycodin D results in decreased expression of CDC37 protein | CTD | PMID:28711525 | quercetin | decreases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of CDC37 mRNA | CTD | PMID:15309432 | SB 431542 | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CDC37 protein | CTD | PMID:37664457 | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of CDC37 mRNA | CTD | PMID:22561333 | tamoxifen | affects expression | ISO | Cdc37 (Mus musculus) | 6480464 | Tamoxifen affects the expression of CDC37 mRNA | CTD | PMID:17555576 | temozolomide | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of CDC37 mRNA | CTD | PMID:31758290 | valproic acid | multiple interactions | ISO | CDC37 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CDC37 mRNA | CTD | PMID:17183730 | valproic acid | increases expression | ISO | CDC37 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CDC37 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | CDC37 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CDC37 mRNA | CTD | PMID:25979313 | |